Quanterix Corp
For the period ended Mar 31, 2025. Filed May 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 12, 2025
QTRX$3.38+16.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(amounts in thousands, except per share data)
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $76,508 | $56,709 |
| Marketable securities | 190,369 | 232,413 |
| Accounts receivable, net of allowance for expected credit losses | 28,258 | 32,141 |
| Inventory | 31,028 | 32,775 |
| Prepaid expenses and other current assets | 8,839 | 9,556 |
| Total current assets | 335,002 | 363,594 |
| Restricted cash | 2,639 | 2,610 |
| Property and equipment, net | 16,457 | 17,150 |
| Intangible assets, net | 16,520 | 4,031 |
| Goodwill | 6,574 | — |
| Operating lease right-of-use assets | 15,971 | 16,339 |
| Other non-current assets | 3,349 | 2,809 |
| Total assets | $396,512 | $406,533 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $6,731 | $6,953 |
| Accrued compensation and benefits | 6,308 | 12,620 |
| Accrued expenses and other current liabilities | 13,314 | 8,851 |
| Deferred revenue | 9,102 | 8,827 |
| Operating lease liabilities | 4,940 | 4,756 |
| Total current liabilities | 40,395 | 42,007 |
| Deferred revenue, net of current portion | 1,098 | 1,073 |
| Operating lease liabilities, net of current portion | 31,467 | 32,615 |
| Non-current portion of contingent consideration | 6,337 | — |
| Other non-current liabilities | 822 | 800 |
| Total liabilities | 80,119 | 76,495 |
| Commitments and contingencies (Note 13) | ||
| Stockholders’ equity: | ||
| Common stock: $0.001 par value per share; Authorized: 120,000 shares; Issued and outstanding: 38,801 and 38,544 shares at March 31, 2025 and December 31, 2024, respectively | 39 | 39 |
| Additional paid-in capital | 808,760 | 803,160 |
| Accumulated other comprehensive loss | (1,821) | (3,080) |
| Accumulated deficit | (490,585) | (470,081) |
| Total stockholders’ equity | 316,393 | 330,038 |
| Total liabilities and stockholders’ equity | $396,512 | $406,533 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.